Study APV20002 Safety and Efficacy Results Through weeek 684 for Pediatric Participants Living with HIV1 Treated with RitonavirBoosted Fosamprenavir Oral SolutionsBased Antiretroviral Therapy

Lisa RossM CottonHaseena CassimHarmony P GargesSven C van DijkmanE et al2024-11-132024-11-13WOS0889-2229https://hdl.handle.net/10539/42445Study APV20002 Safety and Efficacy Results Through weeek 684 for Pediatric Participants Living with HIV1 Treated with RitonavirBoosted Fosamprenavir Oral SolutionsBased Antiretroviral TherapyJournal Article